Alaupovic, Petar
Oklahoma Medical Research Foundation
6 papers on CoChatORCID 0000-0002-6269-2845
Most cited papers
- Verified
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine
Lipoproteins and Cardiovascular HealthAntioxidant Activity and Oxidative Stress
Cited by 1,979
- Verified
Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)
Blankenhorn, D. H., Azen, S. P., Kramsch, D. M., Mack, W. J., Cashin-Hemphill, L., Hodis, H. N., DeBoer, L. W. V., Mahrer, P. R., Masteller, M. J., Vailas, L. I., et al. (1993) · Annals of Internal Medicine
Lipoproteins and Cardiovascular HealthCoronary Interventions and Diagnostics
Cited by 637
- Verified
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial
Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 490
- Verified
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.
Blankenhorn, D. H., Alaupovic, P., Wickham, E., Chin, H. P., & Azen, S. P. (1990) · Circulation
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 278
- Verified
Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia
Skulas-Ray, A. C., Alaupovic, P., Kris-Etherton, P. M., & West, S. G. (2015) · Journal of Clinical Lipidology
Fatty Acid Research and HealthLipoproteins and Cardiovascular Health
Cited by 30
- Verified
In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II
Hannuksela, M. L., Brousseau, M. E., Meyn, S. M., Nazih, H., Bader, G., Shamburek, R. D., Alaupovic, P., & Brewer, H. B. (2002) · Atherosclerosis
Cholesterol and Lipid MetabolismLipid metabolism and disorders
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free